Most sold healthcare stocks in Q2 2021
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2021, measured as net reductions in reported share positions from Q1 2021 into Q2 2021. Notable reductions at the top of this list include ABCELLERA BIOLOGICS INC (ABCL), VIATRIS INC (VTRS), MERCK & CO. INC. (MRK), AVANTOR INC (AVTR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ABCL | ABCELLERA BIOLOGICS INC | -19,340,294 | -$661.62M | 1 | 0 | 0 | 2 | 1 |
| VTRS | VIATRIS INC | -10,798,991 | -$150.67M | 1 | 3 | 5 | 4 | 9 |
| MRK | MERCK & CO. INC. | -6,367,781 | -$523.01M | 2 | 11 | 7 | 0 | 25 |
| AVTR | AVANTOR INC | -4,399,820 | $57.70M | 0 | 2 | 2 | 2 | 4 |
| CERS | CERUS CORP | -4,377,719 | -$28.45M | 0 | 1 | 1 | 0 | 2 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -3,994,127 | -$102.26M | 0 | 2 | 2 | 0 | 5 |
| ATOS | ATOSSA THERAPEUTICS INC | -3,304,140 | -$6.97M | 0 | 0 | 0 | 1 | 0 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | -3,103,216 | -$93.70M | 0 | 0 | 1 | 0 | 1 |
| BPMC | BLUEPRINT MEDICINES CORP | -2,968,871 | -$290.19M | 0 | 1 | 1 | 2 | 3 |
| HCA | HCA HEALTHCARE INC | -2,574,624 | -$422.21M | 0 | 2 | 5 | 1 | 7 |
| ABBV | ABBVIE INC | -2,418,597 | -$189.03M | 0 | 7 | 6 | 2 | 19 |
| MCRB | SERES THERAPEUTICS INC | -2,271,987 | -$15.12M | 0 | 0 | 1 | 1 | 1 |
| ATHA | ATHIRA PHARMA INC | -2,120,653 | -$39.02M | 0 | 0 | 0 | 1 | 0 |
| STXS | STEREOTAXIS INC | -2,024,002 | -$6.82M | 0 | 0 | 2 | 0 | 2 |
| EDIT | EDITAS MEDICINE INC | -1,887,795 | $27.88M | 0 | 0 | 2 | 0 | 2 |
| INVA | INNOVIVA INC | -1,705,200 | -$11.80M | 0 | 0 | 1 | 0 | 1 |
| BIIB | BIOGEN INC | -1,635,982 | -$311.92M | 3 | 4 | 3 | 2 | 11 |
| PHR | PHREESIA INC | -1,438,019 | -$73.30M | 0 | 0 | 2 | 0 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -1,386,050 | -$150.98M | 0 | 2 | 1 | 1 | 3 |
| SRPT | SAREPTA THERAPEUTICS INC | -1,236,273 | -$91.66M | 1 | 1 | 3 | 0 | 5 |
| UNH | UNITEDHEALTH GROUP INC | -1,071,523 | $287.51M | 1 | 7 | 18 | 0 | 31 |
| BKD | BROOKDALE SENIOR LIVING INC | -1,014,982 | $11.64M | 0 | 0 | 1 | 0 | 2 |
| ABUS | ARBUTUS BIOPHARMA CORP | -1,004,500 | -$3.35M | 0 | 0 | 0 | 1 | 0 |
| TWST | TWIST BIOSCIENCE CORP | -992,598 | -$75.48M | 0 | 0 | 2 | 0 | 2 |
| CI | THE CIGNA GROUP | -963,748 | -$307.07M | 1 | 3 | 6 | 1 | 10 |
| PSNL | PERSONALIS INC | -963,163 | -$19.97M | 0 | 0 | 2 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | -949,916 | $630.65M | 1 | 1 | 1 | 0 | 3 |
| ALKS | ALKERMES PLC | -813,756 | $16.00M | 0 | 0 | 2 | 0 | 2 |
| VCYT | VERACYTE INC | -777,410 | -$139.62M | 0 | 1 | 2 | 0 | 3 |
| CVS | CVS HEALTH CORP | -774,985 | $90.30M | 0 | 10 | 4 | 3 | 17 |
| HAE | HAEMONETICS CORP/MASS | -680,922 | -$102.48M | 0 | 0 | 2 | 0 | 2 |
| MOH | MOLINA HEALTHCARE INC | -680,192 | -$98.39M | 0 | 0 | 4 | 0 | 4 |
| HALO | HALOZYME THERAPEUTICS INC | -670,717 | -$28.83M | 0 | 1 | 1 | 1 | 2 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -661,924 | $350.42M | 1 | 1 | 2 | 0 | 6 |
| DXCM | DEXCOM INC | -652,731 | -$107.79M | 0 | 1 | 3 | 1 | 5 |
| NVAX | NOVAVAX INC | -636,745 | -$118.28M | 1 | 2 | 0 | 1 | 3 |
| ALHC | ALIGNMENT HEALTHCARE INC | -625,038 | -$10.34M | 0 | 0 | 0 | 1 | 1 |
| EWTX | EDGEWISE THERAPEUTICS INC | -625,000 | -$50.78M | 0 | 0 | 1 | 0 | 1 |
| REGN | REGENERON PHARMACEUTICALS | -584,696 | -$217.43M | 0 | 0 | 6 | 1 | 6 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -580,600 | -$3.67M | 0 | 0 | 1 | 0 | 1 |
| ARCT | ARCTURUS THERAPEUTICS HOLDIN | -555,671 | -$45.16M | 0 | 1 | 2 | 0 | 3 |
| ACRS | ACLARIS THERAPEUTICS INC | -554,600 | -$32.55M | 0 | 0 | 1 | 0 | 1 |
| ARGX | ARGENX SE - ADR | -549,381 | -$150.53M | 0 | 0 | 1 | 1 | 1 |
| EXEL | EXELIXIS INC | -535,303 | -$92.34M | 0 | 1 | 1 | 0 | 2 |
| AMRN | AMARIN CORP PLC -ADR | -519,042 | -$5.90M | 0 | 1 | 1 | 0 | 2 |
| ACAD | ACADIA PHARMACEUTICALS INC | -504,235 | -$13.91M | 1 | 1 | 0 | 1 | 2 |
| ARDX | ARDELYX INC | -499,273 | -$3.31M | 0 | 0 | 0 | 1 | 0 |
| CLSD | CLEARSIDE BIOMEDICAL INC | -493,910 | -$1.05M | 0 | 0 | 1 | 0 | 1 |
| PLX | PROTALIX BIOTHERAPEUTICS INC | -477,559 | -$2.21M | 0 | 0 | 1 | 0 | 1 |
| CLLS | CELLECTIS - ADR | -458,508 | -$31.35M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q2 2021
What are the most sold Healthcare stocks in Q2 2021?
The most sold healthcare stocks in Q2 2021 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2021?
Among filers in this sector, net reductions were largest in companies such as ABCELLERA BIOLOGICS INC (ABCL), VIATRIS INC (VTRS), MERCK & CO. INC. (MRK), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2021).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.